InflaRx Hits New High, Awaits Phase II Data For Hidradenitis Suppurativa In Q2

Shares of InflaRx N.V. (IFRX) have been on a roll since the beginning of this year, hitting new highs.

from RTT - Biotech http://bit.ly/2UPTEZw
via IFTTT